TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,271,882 | -63.8% | 152,139 | +7.5% | 0.02% | -64.3% |
| Q2 2023 | $3,514,860 | -88.4% | 141,500 | -94.5% | 0.04% | -89.7% |
| Q4 2022 | $30,309,643 | +447.9% | 2,562,100 | +174.2% | 0.41% | +427.3% |
| Q3 2022 | $5,532,000 | +55.4% | 934,436 | +773.9% | 0.08% | +32.8% |
| Q3 2021 | $3,559,000 | -10.0% | 106,932 | +4.9% | 0.06% | -21.6% |
| Q2 2021 | $3,956,000 | -91.1% | 101,980 | -89.0% | 0.07% | -92.5% |
| Q1 2021 | $44,670,000 | +2482.1% | 926,766 | +2687.1% | 0.99% | +2054.3% |
| Q4 2020 | $1,730,000 | -67.7% | 33,252 | -83.4% | 0.05% | -73.7% |
| Q3 2020 | $5,349,000 | -17.5% | 199,875 | -39.9% | 0.18% | -31.9% |
| Q2 2020 | $6,480,000 | – | 332,652 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |